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This 2004 report on tuberculosis control in the Western Pacific Region includes the casesnotified during 2002 and the treatment results of the cohort of patients registered during2001. Data were submitted by the National Tuberculosis Programmes of 35 countries and
areas (accounting for a total population of 1.718 billion1 ). A standard form was used, based on
common definitions and variables. The goal of this report is to provide an update on the epidemiological
situation of tuberculosis in the Region and to show the progress of directly observed treatment
short-course (DOTS) implementation.
Key indicators in tuberculosis control are shown by country in Table 1. In 2002, 35 countries
and areas notified 806 460 tuberculosis cases (all types) and 372 220 new smear-positive pulmonary
cases. Notification rates were 47 per 100 000 and 22 per 100 000, respectively. The notification
rates of all types showed no significant variation since 1993 while notification rates of smear-positive
new cases increased significantly with a rate of change of +3.5%/year. Some 69% of the notified
tuberculosis patients were aged 15-54, the most productive age group, while the group aged
25–34 had the highest tuberculosis burden at 19% (all cases) (Table 3).
The DOTS case detection rate was 33% for all types and 36% for the smear-positive cases
(31% and 37% the previous year, respectively), well short of the World Health Organization
(WHO) target of 70%. It is expected that an acceleration of DOTS expansion should lead to an
increase in case detection, especially of the most contagious cases – those that are pulmonary
smear-positive.
About 77% of the regional population had access to DOTS (68% the previous year) (Table 1).
The treatment success rate was 92% for pulmonary new smear-positive patients registered in
2001. Out of these, 86% were cured, just over the WHO target of 85%.
Among the group of seven countries with a high burden for tuberculosis in the Region (Cambodia,
China, the Lao People’s Democratic Republic, Mongolia, Papua New Guinea, the Philippines, and
Viet Nam) Mongolia and Viet Nam reached WHO targets of 70% DOTS case detection and 85%
treatment success (for new smear-positive cases). Mongolia attained the WHO targets during
2001, two years after full DOTS coverage was reached in 1999. The Philippines, although not yet
reaching the target for detection (58% in 2002) has achieved almost full DOTS coverage, five
years after the introduction of DOTS.
As a whole, the impact of HIV on the TB situation is low in the Region. The estimated percentage
of incident cases attributable to HIV is highest in Cambodia (12%), but it is low in the other TB
high-endemic countries of the Region, particularly in China (0.5%), the Philippines (0.3%) and
Viet Nam (1.5%).
To reach WHO 2005 targets in the Region, treatment success must be improved in some
countries and case detection must be improved in almost all countries.
Summary
1 Population update 2002, Global Tuberculosis Control, WHO, Geneva.
In 2002, 35
countries and
areas notified
806 460
tuberculosis
cases (all types)
and 372 220 new
smear-positive
pulmonary cases
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TABLE 1
Key indicators of tuberculosis control in the Western Pacific Region, 2002
All cases *TB deaths
per 100 000
Success
rate (%)Number
Cure
rate (%)
New
Smr+ (%)
All
cases (%)
New
Smr+
All
cases
New
 Smr+
All
cases
New
 Smr+ (%)
All
cases (%)
New
 Smr+ %
a
 60
19 544
 350
13 810
1 294 867
 18
 831
 241
 160
6 981
127 478
 87
47 430
5529
 460
23 965
 76
 52
 108
2559
 13
 224
3846
 2
 20
5586
78 580
 0
 176
4183
 463
 2
 103
 10
 207
80 278
 15
1 718 314
Country
American Samoa
Australia
Brunei
Cambodia
China
Cook Islands
Fiji
French Polynesia
Guam
Hong Kong (China)
Japan
Kiribati
Republic of Korea
Lao People’s Democratic Republic
Macao (China)
Malaysia
Mariana Islands
Marshall Islands
Micronesia
Mongolia
Nauru
New Caledonia
New Zealand
Niue
Palau
Papua New Guinea
Philippines
Pitcairn
Samoa
Singapore
Solomon Islands
Tokelau
Tonga
Tuvalu
Vanuatu
Viet Nam
Wallis & Futuna
Western Pacific
Pop.
b
  4
1 013
 221
24 610
462 609
 1
 150
 66
 51
6608
32 828
 189
34 967
2621
 388
14 389
 53
 51
 127
3829
 5
 65
 329
 2
 11
5324
118 408
 30
1516
 256
 29
 13
 101
95 577
 19
806 460
All
cases
Notification in DOTS and other areas
*Number of
estimated cases
u
6.0
1.0
4.0
107.1
21.0
5.7
5.0
3.8
16.4
8.0
4.0
7.0
10.2
29.0
10.0
15.0
13.0
10.0
12.7
37.0
2.2
16.9
1.1
2.0
10.0
56.0
57.2
0.0
5.0
4.9
14.8
6.3
3.0
6.0
16.3
25.1
4.3
21.7
Case detection rate
Pop. accessible
to DOTS
t
66
56
92
96
100
85
80
71
78
75
86
77
89
79
74
86
100
87
100
84
9
100
67
88
77
88
89
92
88
91
100
92
Number of cases
in DOTS areas
%
s
18
44
89
94
100
85
80
53
72
51
79
67
86
0
0
36
100
83
100
84
0
100
45
74
41
0
66
67
65
89
100
86
Number of cases in
non-DOTS areas
r=n/h
12
25
121
52
27
40
66
82
48
51
33
233
0
43
77
78
68
84
50
69
114
23
48
370
15
58
74
39
57
163
37
82
36
Rate
q=m/g
11
54
107
32
27
18
59
90
35
83
46
241
0
28
91
63
77
108
129
71
128
32
81
333
37
47
56
44
61
93
37
62
33
**DOTS case
detection rate
Number
p
1
83
0
0
14 733
0
0
0
0
389
4635
0
11 345
0
12
0
0
0
0
0
0
0
0
0
0
0
0
0
238
0
0
0
7
0
31 443
DOTS cure and
success rate
Rate
o
2
410
0
0
74 414
0
0
0
0
1214
13 527
0
34 967
0
30
0
0
0
0
0
0
0
0
0
0
0
0
0
738
0
0
0
31
0
9
125 342
n
1
127
112
17 258
180 239
1
75
27
31
1501
6172
82
0
1829
135
7958
21
18
22
1670
2
21
88
1
9
926
65 148
18
311
108
23
0
31
56 811
1
340 777
*2003 update, WHO Geneva.
**DOTS detection rate is the proportion of total estimated cases who are diagnosed and treated under DOTS.
m
2
603
221
24 610
388 195
1
150
66
51
5394
19 301
189
0
2621
358
14 389
53
51
127
3829
5
65
329
2
11
5324
118 408
30
778
256
29
13
70
95 577
10
681 118
*Pop.
x 1000
l
100
54
100
100
78
100
100
100
100
100
62
100
0
77
100
100
100
100
90
100
100
100
100
100
100
24
98
100
100
100
98
0
81
100
100
77
k
60
10 554
350
13 810
1 004 817
 18
 831
 241
160
6981
78 654
87
 0
4257
 460
23 965
76
52
97
2559
 13
 224
3846
 2
 20
1341
77 008
 176
4183
 463
 101
 0
 168
80 198
 15
1 315 786
j=d/h
24
42
121
52
30
40
66
82
48
65
57
233
59
43
83
78
68
84
50
69
114
23
48
370
110
15
58
74
69
57
163
0
45
82
50
40
New Smr+
i=b/g
22
90
107
32
32
18
59
90
35
102
78
241
81
28
99
63
77
108
129
71
128
32
81
333
61
37
47
56
85
61
93
407
54
62
425
39
h
8
505
93
33 450
656 017
3
114
33
65
2918
18 885
35
19 325
4224
176
10 190
31
21
44
2411
2
91
183
0
8
6358
113 087
0
24
798
189
0
14
1
84
69 365
2
938 756
g
18
1126
206
75 788
1 459 103
6
253
73
145
6488
41 990
78
42 950
9390
393
22 708
69
47
98
5357
4
203
408
1
18
14 202
251 442
0
54
1785
420
0
31
3
187
154 513
4
2 089 562
f=d/b
50
21
51
70
42
100
50
41
61
29
33
43
32
70
38
55
40
35
17
44
40
32
27
0
100
17
55
60
36
42
79
0
38
59
5
46
e
3
1
32
125
15
6
9
11
19
27
8
94
24
33
32
33
28
35
20
65
15
9
2
50
45
17
83
10
13
23
22
0
18
71
7
21.7
d
 2
 210
 112
17 258
194 972
 1
 75
 27
 31
1890
10 807
 82
11 345
1829
 147
7958
 21
 18
 22
1670
 2
 21
 88
 1
 9
 926
65 148
 18
 549
 108
 23
 0
 38
56 811
 1
372 220
c
 7
5
63
178
36
6
18
27
32
95
26
217
74
47
84
60
70
98
118
150
38
29
9
100
55
95
151
17
36
55
28
130
49
119
127
46.9
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2This report is based on case notification and treatment outcome data supplied by nationalcontrol programmes to the World Health Organization (WHO) for 2002, using a standarddata collection form, with common definitions and variables.
1.1 Notification of tuberculosis cases by type of
tuberculosis in 2002
In 2003, 35 out of 37 countries and areas of the Western Pacific Region with a combined population
of 1.718 billion sent tuberculosis data for 2002. Together, they notified 806 460 tuberculosis cases
(all types) (46.9 per 100 000 population), of whom 372 220 were new smear-positive pulmonary
cases (21.7 per 100 000) (Table 1, Charts 1 and 2).
The two non-reporting areas – Tokelau and the Pitcairn Islands, have a combined population
of only around 2000. Notification by country is given in Table 1.
All types
Among the 806 460 tuberculosis cases (all types) in the Region (Figure 1), China notified 57%, the
Philippines 15%, Viet Nam 12%, the Republic of Korea 4%, Japan 4% and Cambodia 3%.
Together, the 29 other countries notified only 5%. Nine countries reported a notification rate (all
types) greater than 100, and 10 countries reported a rate lower than 30.
Review of
tuberculosis
epidemiology
CHAPTER 1
The regional
average notification
rate for new smear-
positive cases was
21.7 per
100 000 population,
with the highest rate
in Cambodia (125)
FIGURE 1
Distribution of notified tuberculosis (all types) by country, Western Pacific Region, 2002
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Pulmonary new smear-positive cases
Among the 372 220 new smear-positive cases in the Region, China notified 194 972 cases (52%),
the Philippines 65 148 (18%), Viet Nam 56 811 (15%), Cambodia 17 258 (5%), Korea 11 345
(3%) and Japan 10 807 (3%). The 29 other countries notified together 15 879 cases (4%) (Tables
1 and 6).
The regional average notification rate for new smear-positive cases was 21.7 per 100 000
population, with the highest rate in Cambodia (125). The rate ranged between 25 and 100 in 20
countries. China notified 15 new smear-positive cases per 100 000 population. Four industrialized
countries (Japan, Australia, New Zealand and Singapore) and 10 Pacific island countries (PICs)
had lower rates (Table 1).
The proportion of new smear-positive cases out of all notified cases was 46% for the Region
(42% in China). Eleven countries, including four of the seven with the highest burden (Cambodia,
the Lao People’s Democratic Republic, the Philippines, Viet Nam) notified proportions higher than
50% (Table 1).
The 55 528 extra-pulmonary cases reported represented 7% of all notified cases (Table 6).
FIGURE 2
Notified cases by type of tuberculosis in DOTS and non-DOTS areas, Western Pacific Region,
2002
1.2 Notification of the new smear-positive
pulmonary cases by age and gender in 2002
Some 68% of new smear-positive cases are aged between 15 and 54, the most productive age
group, with the highest concentration in the group aged 25–34 (19%) (Table 7).
Two male tuberculosis smear-positive cases are notified for every female one (sex ratio: 2.1) in
the Region (Table 7). The sex ratio was 0.8 in the 0–14-year-old group (more females than
males), 1.4 in the 15–24 year old group and then increased in the older age groups (Figure 3).
	
		
	
			
	
		

	
	
				
    
 !"#  !"#
T U B E R C U L O S I S  C O N T R O L  I N  T H E  W H O  W E S T E R N  P A C I F I C  R E G I O N  2 0 0 4
4
1.3 Case detection rate in 2002
The case detection rate (see Appendix 1 for definition) was 39% for all tuberculosis cases and 40%
for new smear-positive cases (Table 1). In other words, in the Region, the 806 460 notified cases (all
types) represented 39% of the 2 089 562 estimated cases (all types) and the 372 220 notified new
smear-positive cases represented 40% of the 938 756 estimated new smear-positive cases.
DOTS areas reported 36% of all new estimated smear-positive cases (340 777 new smear-
positive cases out of 938 756 estimated cases) (Table 1).
Figures of estimated cases (annual incidence) are WHO provisional estimates to appear in WHO
Report 2004 Global Tuberculosis Control, with projections based on “Global Burden of Tuber-
culosis”,2 published in 1999, and “The Growing Burden of Tuberculosis”,3 published in 2003.
1.4 Trends in notification
Trends in notification for all types and new smear-positive cases are given by country in four tables
(8 to 11) in Part II. Overall notification rates from 1993 to 2002 both for all types and new smear-
positive cases are presented in Figure 4. Trends in notification may reflect variations in performance
in case finding as well as changes in the burden of the disease. Moreover, trends in case detection
rates are also affected by changes in the estimated incidence. Regional trends are very influenced
by trends in China.
From 1993 to 2002, the rates of notified new tuberculosis cases (all types) have not increased
significantly in the WPR. (p=0.3, See Annex 3 for details on statistical methods). However, there
was a statistically significant increasing trend in case notification rates of smear-positive new cases
(+3.2%/yr, p=0.034).
2 Dye C., Scheele S., Dalin P. et al. Global Burden of Tuberculosis. Estimated Incidence, Prevalence, and
Mortality by Country. JAMA 1999; 282: 677–686.
3 Corbett EL, Watt CJ, Walker N. et al. The Growing Burden of Tuberculosis. Global Trends and Interactions
With the HIV Epidemic. Arch Int Med 2003; 163(9): 1009-1021.
DOTS areas
reported 36% of
all new estimated
smear-positive
cases (340 777
new smear-
positive cases out
of 938 756
estimated cases)
FIGURE 3
Notification of new smear-positive cases by age and gender, DOTS and non-DOTS areas,
Western Pacific Region, 2002 (%)
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FIGURE 4
Trend in notification rates of tuberculosis, Western Pacific Region, 1993–2002 (rate per 100 000)
FIGURE 5
Trend in notification of smear-positive cases in Cambodia, China, Viet Nam and the Philippines,
Western Pacific Region, 1995-2002 (rate per 100 000)
The notification of new tuberculosis cases (all types) increased in Papua New Guinea since the
previous year (+53%), Cambodia (+28%), the Philippines (+11%), the Lao People’s Democratic
Republic (+10%), Mongolia (+9%) and slightly in Viet Nam (+5%).
There was a statistically significant increase in new case notification rates in China from 1993 to
2002 of all types (+2.9%/yr, p=0.015) and smear-positive new cases (+8.6%/yr, p=0.006).
1.5 Trends in case detection
Case detection makes slow progress in the Region, and only 36% of all estimated new smear-
positive cases were notified by DOTS programs to WHO. Estimates of incidence were revised in a
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substantial manner in several countries. There was no significant increase in case detection rates
of smear-positive cases between 1998 and 2002, but estimates of prevalence and incidence were
revised and improved during the period, leading to fluctuations of the case detection rates between
years. In particular, data from China was revised for this report: re-treatment smear-positive cases
are no longer included in the new smear-positive category, resulting in slightly lower case detections
of smear-positive cases in China and as a result, in the Region.
Although DOTS population coverage and case detection have been accelerating in some
countries, particularly in the Philippines, the annual increment in case notifications under DOTS has
been steady but slow in China where 22% of the population (around 290 million people) do not yet
have access to DOTS. More data analysis is needed in China to investigate the reasons for low
case detection and obstacles to DOTS expansion.
If the current rate of progress is maintained, the global target of 70% case detection rate will be
difficult to reach in the Region in 2005. In total, around 250 000 additional smear-positive new
cases will need to be detected per year to reach the target.
1.6 HIV and tuberculosis
The HIV epidemic has reached a generalized stage only in Cambodia where the prevalence of
HIV infection among those aged 15 to 49 years was estimated to be 2.7% in 2002. In other
countries affected by HIV in the Region,4 particularly in Viet Nam and China, the HIV epidemic is still
at a concentrated stage. In China, HIV prevalence data indicated a focused, explosive spread of
infections among injecting drug users (IDUs) and no significant spread in the non-IDU population.
Although HIV/AIDS cases have been detected in all provinces, HIV transmission is focused
primarily among IDUs in certain provinces. In Viet Nam, the prevalence is highest among IDUs
(24% in 2000) but sexual transmission of HIV is increasing among female sex workers.
Table 12 shows data used to compute estimates of TB morbidity and mortality. Tables 13 and 14
show estimates of tuberculosis and HIV co-infection numbers and rates, and the estimated impact
of HIV on the tuberculosis situation.
The percentage of HIV-attributable tuberculosis cases in the Region is 1% of all adult cases, the
lowest percentage among all WHO Regions (the global percentage of tuberculosis cases attribut-
able to HIV is 10%).
The estimated percentage of incident cases attributable to HIV is highest in Cambodia (11.9%),
but is low in the other countries with a high burden of tuberculosis in the Region (see Chapter 3 for
details on the grouping of countries), particularly in China (0.5%), the Philippines (0.3%) and Viet
Nam (1.5%). With the exception of Cambodia, the percentages of incident cases of tuberculosis
attributable to HIV are lower in countries with a high burden of TB than in several countries with an
intermediate burden (Singapore, 5,5%) and countries with low incidence of TB (Australia 2%).
1.7 Tuberculosis mortality
It is estimated that 372 900 deaths from tuberculosis occurred in the Region in 2001, i.e. 21.7
deaths from tuberculosis per 100 000 population. The percentage of tuberculosis deaths attributable
to HIV in the Region is 1.4%. The death rate from tuberculosis per 100 000 population is highest
in Cambodia (107.1, of which 15.1% are attributable to HIV), as compared to 57.2 in the Philippines,
56 in Papua New Guinea, 25.1 in Viet Nam and 21 in China.
4 http://www.who.int/emc-hiv/fact_sheets/index.html, accessed 15 December 2003
7Among the 35 countries and areas in the Region that reported in 2002, 33 had at least partof their population served by DOTS units, compared to 18 in 1998. Thirty-one countrieshad a tuberculosis manual and have a special budget for tuberculosis control. Short-
course chemotherapy is used in all DOTS areas by 31 countries. Thirty-two countries have
implemented a mechanism for cohort analysis of treatment outcomes.
2.1 Population with access to DOTS
The population in the Region with access to DOTS increased from 67% in 2000 to 77% in 2002
(Table 1). DOTS was applied in 94% of operational health units (6295 out of 6695) in the Region
and in 56% of the health units in China (1551 out of 2754).
Twenty-five countries reached 98% DOTS coverage or above (Table 1).
2.2 DOTS enrolment
In 2002, 84% of all cases and 92% of new smear-positive cases in the Region were diagnosed
and treated under DOTS. This is a rapid improvement compared to 1999, when the figures were
69% for all cases and 78% for new smear-positive cases. The increase was particularly marked
in the Philippines (from 28% in 1999 to 100% in 2001) and Japan (from 37% in 1999 to 57% in
2002). The proportion of new cases notified in DOTS areas in China continued to increase: 84%
in 2002, as compared to 75% in 2001.
Review of DOTS
implementation and
treatment results
CHAPTER 2
Twenty-five
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2.3 Treatment results of new smear-positive cases
In DOTS areas, the treatment cure and success rate were 86% and 92%, respectively, for the
cohort of 322 220 new pulmonary smear-positive cases registered for treatment outcome evaluation
in 2001 (they represented 85% of the 379 060 cases notified that year) (Table 15). The percentage
of cases not evaluated was 1%. In China, 83% of new smear-positive cases were registered for
treatment results (176 476 out of 212 766 notified in 2001) and the treatment cure rate was 94%.
In non-DOTS areas, the treatment success rate was 73% of 24 962 cases (59% of the 42 622
cases notified) (Table 16). In China, 58% of the 24 286 notified cases in 2001 were evaluated and
the treatment success was 86%.
2.4 Treatment results of re-treatment cases
In DOTS areas, 44 652 re-treatment cases were registered for treatment outcomes evaluation
(including relapses, failures and returns after treatment interruption). The treatment success rate
was 90.7%, the cure rate was 84.9% and 1.3% of the cases were not evaluated (Table 17).
In non-DOTS
areas, the
treatment
success rate was
73% of 24 962
cases (59% of the
42 622 cases
notified)
FIGURE 6
Trends in population with access to DOTS and DOTS enrolment rate (all cases) in the Western
Pacific Region, 1995–2002 (%)
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FIGURE 7
Treatment success for new smear-positive cases in DOTS and non-DOTS areas, 2001 cohort (%)
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3.1 Tuberculosis in countries with a high burden
Seven countries in the Region – Cambodia, China, the Lao People’s Democratic Republic,Mongolia, Papua New Guinea, the Philippines and Viet Nam – have been identified ascountries with a high burden of tuberculosis.
In 2002, these seven countries accounted for 86% of the Region’s population and 94% of all
estimated cases. They notified 88% of all cases (712 978 out of 806 460) and 91% of the smear-
positive cases in the Region (338 614 out of 372 220) (Table 1). The combined DOTS case
detection was 36% for all types and 38% for the new smear-positive cases. DOTS expansion
made the most progress in this group of countries. In 2002, 80% of the population had access to
DOTS (71% the previous year). Treatment success exceeded 85% in five of these countries
(including China). Mongolia and Viet Nam have reached the targets of 70% case detection and
85% treatment success for new smear-positive cases. Mongolia attained the WHO targets for the
first time in 2001, two years after reaching full DOTS coverage in 1999. Viet Nam has been
maintaining high case detection and treatment success for several years. Cambodia, China and
the Philippines have all exceeded the 85% treatment success target.
3.1.1 TB control policies and DOTS components in countries with a
high burden
All countries with a high burden of TB are using WHO-recommended National TB guidelines and
have central procurement and distribution systems for TB drugs and national reference laboratories.
Five countries allot tuberculosis its own budget. DOTS is implemented in all public hospitals in
Cambodia, Mongolia, the Philippines and Viet Nam, and in 71% of health centre units in China,
60% in the Lao People’s Democratic Republic and 22% in Papua New Guinea. All the countries
use sputum smear microscopy for diagnosis (with the exception of Papua New Guinea, where it is
used in some units only). DOT is applied in all public health units within DOTS areas. Treatment
and smear microscopy examinations are free for the patients in six countries, while China has a
patient fee system in non-DOTS areas. Reporting of treatment results is based on cohort analysis
in all units in all countries with a high burden of tuberculosis. Screening and treatment of contact
children is carried out in some units only.
3.1.2 Notification in countries with a high burden
In 2002, the notification rate for all cases exceeded 100 per 100 000 population in four of the seven
countries with a high burden of TB: 178 in Cambodia, 151 in the Philippines, 150 in Mongolia and
119 in Viet Nam. The estimated incidence5  of smear-positive cases was 24.3, reflecting largely the
TB situation in China. The case detection rate was 32% in China, where around 70% of the
Grouping of
countries
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seven countries
accounted for
86% of the
Region’s
population and
94% of all
estimated cases
5 Based on the 2001 update of estimated cases from WHO, Geneva.
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estimated cases of the Region reside. Therefore, DOTS expansion in China is a pre-condition for
reaching the WHO target of 70% case finding in the Region.
The notification rate of new smear-positive cases increased between 1995 and 2001 in Mongolia.
It also increased slightly in Viet Nam, the Lao People’s Democratic Republic and China, and over
the past year in Cambodia and the Philippines. Fluctuations in the Papua New Guinea results are
mostly due to significant variations in the reporting system (Figure 8).
3.1.3 DOTS implementation in countries with a high burden
DOTS has made faster progress in countries with a high burden than in others. By the end of 2002,
79.9% of the population in the countries with a high burden had access to DOTS, compared to
63% in 1998. Nearly all of the populations of Viet Nam, Mongolia and Cambodia can access
DOTS (Table 2). DOTS coverage also increased to 98% in the Philippines, 77% in the Lao
People’s Democratic Republic, and 24% in Papua New Guinea. China’s population with access to
DOTS increased to 78% (68% the previous year).
FIGURE 8
Trend in notification rate of new smear-positive cases, countries with a high burden of TB,
Western Pacific Region, 1995–2002 (rate per 100 000)
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TABLE 2
DOTS in countries with a high burden, Western Pacific Region, 1998–2001 (%)
Pop. accessible
to DOTS
DOTS case detection
rate* new S+
* Case detection rates and DOTS case detection rates have been made available since the publication of estimated cases in Global
Burden of Tuberculosis, in 1999. Data from China was revised in 2003: re-treatment smear-positive cases are no longer included in the
smear-positive new category, resulting in slightly lower case detections of smear-positive cases in both China and the WPR as a whole.
Case detection
rate* new S+
Country 1998 2002 1998* 2002 1998 2002
Cambodia 100 100 54 52 54 52
China 64 78 33 30 30 27
Lao People’s Democratic Republic 71 77 39 43 39 43
Mongolia 97 100 57 69 51 69
Papua New Guinea 9 24 41 15 8 15
Philippines 17 98 70 58 10 58
Viet Nam 96 100 83 82 81 82
Countries with a high burden 63 80 43 38 32 37
Other countries 24 56 66 62 22 31
Western Pacific Region 58 77 44 40 32 36
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The population with access to DOTS increased the most in the Philippines – from 17% in 1998
to 98% in 2002. In China, an increase of 14 percentage points since 1998 translates as 176 million
more population with access to DOTS (Figure 9).
Patients treated
under DOTS
benefited from
better
management and
follow-up
FIGURE 9
Comparison of population with access to DOTS in countries with a high burden, Western
Pacific Region, 1998 and 2002 (%)
3.1.4 Treatment results in countries with a high burden
Better treatment outcomes were observed in the countries with a high burden, with the greatest
DOTS enrolment. Treatment success in DOTS areas was 93% in countries with a high burden
(new smear-positive cases registered in 2001), compared to 78% in other countries and the
proportion of patients not evaluated6 was only 1% in countries with a high burden, compared to
5% in other countries (Table 3).
6 Among the cohort of new smear-positive pulmonary patients registered for a treatment outcome in 2001.
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TABLE 3
Treatment outcomes of new smear-positive in seven high-burden countries, cohort 2001 in DOTS areas, Western Pacific Region
Registered Non evaluated Completed Transferred Treatment
Country number  (% ) Cured treatment Defaulted Failed Died out success
Cambodia 14 277 0.0 89.3 2.5 2.9 0.4 4.0 0.9 91.8
China 176 476 0.7 94.0 2.1 0.7 0.7 1.1 0.6 96.1
Lao People’s Democratic Republic 1484 3.8 66.8 9.8 8.4 0.7 8.0 2.6 76.6
Mongolia 1631 0.1 83.4 3.3 3.9 4.5 2.3 2.6 86.7
Papua New Guinea 469 3.8 45.4 21.5 22.8 0.4 3.4 2.6 67.0
Philippines 55 402 0.0 74.5 13.1 6.0 1.3 2.3 2.7 87.6
Viet Nam 55 236 1.9 89.2 1.6 1.5 0.9 3.0 1.9 90.8
Total 304 975 0.8 89.1 4.1 2.0 0.9 1.9 1.3 93.2
Other countries 17 245 5.2 27.2 50.2 4.8 2.4 9.3 0.7 77.5
Western Pacific Region 322 220 1.0 85.8 6.6 2.2 1.0 2.3 1.2 92.4
Outcomes of treatment (%)
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The cure rate was 89.1% in countries with a high burden (27% in others) (Table 3). Patients
treated under DOTS benefited from better management and follow-up (including sputum examina-
tions at the end of treatment to confirm that the patient had been “cured”).
By country, the treatment success for pulmonary new smear-positive cases exceeded 85% in
five countries, while it was 76.6% in the Lao People’s Democratic Republic (compared to 62% in
1997) and 67% in Papua New Guinea (Table 3). The Philippines’ figures improved from 83% in
1997 to 87.6% in 2001. Meanwhile Cambodia, China and Viet Nam have maintained high treat-
ment success rates since 1997.
3.2 Tuberculosis in countries with an intermediate
burden
Countries with a intermediate burden of TB include Brunei Darussalam, Hong Kong (China),
Japan, the Republic of Korea, Macao (China), Malaysia and Singapore. A stagnation of notification
rates (defined as a slow-down or reversal of the annual decline of the crude notification rate) is
observed in all countries with an intermediate burden over the last decade, with the exception of the
Republic of Korea (mean annual change: -11%). However, the causes of this stagnation vary
between countries. Although ageing of the population and the epidemic appears to be a major
contributing factor, depending on the local situation, other factors, such as migration and HIV, do
play an important role.
TABLE 4
Mean annual change in notification rate in countries with an intermediate burden (%)
Mean annual change 1960–70 1970–80 1980–90 1990–99/00
Brunei Darussalam -11 -3 -6 5
Hong Kong (China) -4 -5 -3 0
Japan -10 -4 -2
Republic of Korea -4 -11
Macao (China) -12 -1
Malaysia -3 1
Singapore -6 -4 -7 -1
In Hong Kong (China) and Singapore, stagnation is mainly due to ageing of the tuberculosis
epidemic and ageing of the population. Some risk groups seem to emerge, such as the urban poor,
including the homeless. Population movements may have some importance, such as migrant
workers in Singapore and travel in and out of mainland China into Hong Kong (China).
In Malaysia, increasing tuberculosis notification rates in the 25-44 age group and the relatively
high case fatality rates in this age group, suggest that tuberculosis is increasing at least in part due
to the spread of HIV infection in this population.
In Brunei Darussalam and Macao (China), changes in diagnostic practices and/or notifications,
as well as ageing of the tuberculosis epidemic, appear most important, but transmission from migrant
workers seems to play a role.
The Republic of Korea shows a continuing decline. However, some stagnation due to ageing of
the epidemic may be expected within the next 20 years, as the annual risk of infection has declined
to approximately 0.5% and therefore has limited scope for further decline.
T U B E R C U L O S I S  C O N T R O L  I N  T H E  W H O  W E S T E R N  P A C I F I C  R E G I O N  2 0 0 4
14
3.3 Tuberculosis in Pacific island countries
The Pacific island countries (PICs) include American Samoa, Cook Islands, Fiji, French Polynesia,
Guam, Kiribati, Northern Mariana Islands, Marshall Islands, the Federated States of Micronesia,
Nauru, New Caledonia, Niue, Palau, Pitcairn, Samoa, Solomon Islands, Tokelau, Tonga, Tuvalu,
Vanuatu, Wallis and Futuna.
Case notification rates vary widely among PICs. Rates also fluctuate with time due to the very
small population size of many countries. However, higher rates are consistently observed north of
the equator, with the exception of Guam, as compared to countries located south of the equator.
Notification rates (all types) in Kiribati have been consistently higher than 200 per 100 000 since
1998, and are the highest rates recorded in the Western Pacific Region. The widely scattered
populations in PICs create a great challenge to the organization of tuberculosis control.
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All cases *TB deaths
per 100 000
Success
rate (%)Number
Cure
rate (%)
New
Smr+ (%)
All
cases (%)
New
Smr+
All
cases
New
 Smr+
All
cases
New
 Smr+ (%)
All
cases (%)
New
 Smr+ %
a
 60
 18
 831
 241
 160
 87
 76
 52
 108
 13
 224
 2
 20
 0
 176
 463
 2
 103
 10
 207
 15
2868
Country
American Samoa
Cook Islands
Fiji
French Polynesia
Guam
Kiribati
Mariana Islands
Marshall Islands
Micronesia
Nauru
New Caledonia
Niue
Palau
Pitcairn
Samoa
Solomon Islands
Tokelau
Tonga
Tuvalu
Vanuatu
Wallis & Futuna
Western Pacific
Pop.
b
 4
 1
 150
 66
 51
 189
 53
 51
 127
 5
 65
 2
 11
 30
 256
 29
 13
 101
 19
1223
All
cases
Notification in DOTS and other areas
*Number of
estimated cases
u
6.0
5.7
5.0
3.8
16.4
7.0
13.0
10.0
12.7
2.2
16.9
2.0
10.0
5.0
14.8
6.3
3.0
6.0
16.3
4.3
21.7
Case detection rate
Pop. accessible
to DOTS
t
100
85
80
71
86
74
86
100
100
84
100
77
89
92
88
100
92
Number of cases
in DOTS areas
%
s
100
85
80
53
79
0
36
100
100
84
100
41
66
67
65
100
86
Number of cases in
non-DOTS areas
r=n/h
13
50
68
84
53
257
75
95
55
106
25
333
78
63
164
40
69
Rate
q=m/g
11
20
61
93
39
267
84
119
143
119
35
333
58
67
91
41
74
**DOTS case
detection rate
Number
p
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7
8
DOTS cure and
success rate
Rate
o
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31
9
42
n
1
1
75
27
31
82
21
18
22
2
21
1
9
18
108
23
0
31
1
492
*2003 update, WHO Geneva.
**DOTS detection rate is the proportion of total estimated cases who are diagnosed and treated under DOTS.
m
2
1
150
66
51
189
53
51
127
5
65
2
11
30
256
29
13
70
10
1181
*Pop.
x 1000
l
100
100
100
100
100
100
100
100
90
100
100
100
100
100
100
98
0
81
100
98
k
60
 18
 831
 241
160
87
76
52
97
 13
 224
 2
 20
 176
 463
 101
 0
 168
 15
2804
j=d/h
25
50
68
84
53
257
75
95
55
106
25
333
121
78
63
164
0
50
45
70
New Smr+
i=b/g
22
20
61
93
39
267
84
119
143
119
35
333
67
58
67
91
163
59
389
77
h
8
 2
 110
 32
 59
 32
 28
 19
 40
 2
 83
 0
 7
 23
 172
 14
 1
 77
 2
 712
g
 18
 5
 246
 71
 132
 71
 63
 43
 89
 4
 185
 1
 17
 52
 382
 32
 8
 170
 5
1593
f=d/b
50
100
50
41
61
43
40
35
17
40
32
0
100
60
42
79
0
38
5
41
e
3
6
9
11
19
94
28
35
20
15
9
50
45
10
23
22
0
18
7
17.4
d
 2
 1
 75
 27
 31
 82
 21
 18
 22
 2
 21
 1
 9
 18
 108
 23
 0
 38
 1
 500
c
 7
6
18
27
32
217
70
98
118
38
29
100
55
17
55
28
130
49
127
42.6
TABLE 5
Key indicators of tuberculosis control in the Pacific island countries, 2002
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TABLE 6
Notification of tuberculosis cases by type, Western Pacific Region, 2002
% out % out % of all SS+ % out % out
 of the of new  out of all of the of the
Country New  total  pulmonary Relapse  pulmonary Total total Total total
Extra-
pulmonarySputum negativeSputum positive
Pulmonary
American Samoa 2 50 100 0 100 0 0 2 50 4
Australia 210 21 55 5 56 168 17 472 47 1013
Brunei Darussalam 112 70 10 76 39 18 47 21 221
Cambodia 17 258 70 83 787 86 2852 12 3711 15 24610
China 194 972 42 48 26 077 54 185 840 40 17 679 4 462 609
Cook Islands 1 100 100 0 100 0 0 0 0 1
Fiji 75 50 68 2 69 34 23 39 26 150
French Polynesia 27 41 52 8 67 17 26 14 21 66
Guam 31 61 76 2 80 8 16 5 10 51
Hong Kong (China) 1890 29 37 232 42 2919 44 804 12 6608
Japan 10 807 33 43 1126 47 13 361 41 6356 19 32 828
Kiribati 82 43 73 3 76 27 14 77 41 189
Republic of Korea 11 345 32 41 2957 52 13 057 37 3971 11 34 967
Lao People’s Democratic Republic 1829 70 78 87 82 418 16 287 11 2621
Macao (China) 147 38 43 18 48 178 46 41 11 388
Malaysia 7958 55 61 0 61 5063 35 1368 10 14 389
Mariana Islands 21 40 40 0 40 32 60 0 0 53
Marshall Islands 18 35 50 0 50 18 35 15 29 51
Micronesia 22 17 42 4 49 27 21 22 17 127
Mongolia 1670 44 63 134 68 859 22 1166 30 3829
Nauru 2 40 100 0 100 0 0 3 60 5
New Caledonia 21 32 45 1 47 25 38 18 28 65
New Zealand 88 27 51 5 53 81 25 105 32 329
Niue 1 50 100 0 100 0 0 1 50 2
Palau 9 82 90 0 90 1 9 0 0 11
Papua New Guinea 926 17 30 77 33 2040 38 2281 43 5324
Philippines 65 148 55 56 3628 59 47 520 40 2112 2 118 408
Pitcairn 0
Samoa 18 60 72 0 72 7 23 5 17 30
Singapore 549 36 57 91 67 320 21 154 10 1516
Solomon Islands 108 42 51 2 52 101 39 45 18 256
Tokelau
Tonga 23 79 85 1 89 3 10 2 7 29
Tuvalu 0 0 0 0 0 5 38 13
Vanuatu 38 38 45 1 46 45 45 17 17 101
Viet Nam 56 811 59 70 5469 77 18 593 19 14 704 15 95 577
Wallis & Futuna 1 5 6 0 6 17 89 1 5 19
Total 372 219 46 53 40 727 58 293 670 36 55 528 7 806 458
All
types
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TABLE 7
Age and sex distribution of new sputum smear-positive (SS+) cases in DOTS and non-DOTS areas, Western Pacific Region,* 2002
Country 0-14 15-24 25-34 35-44 45-54 55-64 >=65 Total 0-14 15-24 25-34 35-44 45-54 55-64 >=65 Total 0-14 15-24 25-34 35-44 45-54 55-64 >=65 Total
American Samoa 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1
Australia 1 15 20 26 19 13 34 128 0 15 21 15 6 4 23 84 1 30 41 41 25 17 57 212
Brunei Darussalam 2 15 15 7 6 8 14 67 0 11 9 8 5 5 7 45 2 26 24 15 11 13 21 112
Cambodia 54 791 1449 1956 1799 1624 1432 9105 54 600 1114 1737 1898 1650 1100 8153 108 1391 2563 3693 3697 3274 2532 17 258
China 925 17 933 25 242 22 645 23 884 19 564 22 562 132 755 1152 13 250 15 188 10 505 8796 6586 6740 62 217 2077 31 183 40 430 33 150 32 680 26 150 29 302 194 972
Cook Islands 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1
Fiji 0 13 9 8 5 7 2 44 0 8 6 8 2 5 2 31 0 21 15 16 7 12 4 75
French Polynesia 0 4 2 1 3 3 1 14 0 4 2 1 2 2 2 13 0 8 4 2 5 5 3 27
Guam 3 3 5 5 6 12 4 38 5 1 6 3 3 2 7 27 8 4 11 8 9 14 11 65
Hong Kong (China) 2 99 104 162 206 218 545 1336 8 97 115 89 56 35 154 554 10 196 219 251 262 253 699 1890
Japan 2 191 549 579 1192 1334 3747 7594 3 192 395 259 248 308 1808 3213 5 383 944 838 1440 1642 5555 10 807
Kiribati 5 11 1 7 7 7 0 38 5 15 8 8 3 4 1 44 10 26 9 15 10 11 1 82
Republic of Korea 20 806 1333 1374 1265 1029 1390 7217 19 759 854 456 334 377 1329 4128 39 1565 2187 1830 1599 1406 2719 11 345
Lao People’s Democratic Republic 4 86 159 220 223 227 185 1104 2 72 141 151 152 117 90 725 6 158 300 371 375 344 275 1829
Macao (China) 1 13 8 21 20 17 21 101 1 7 10 7 9 1 11 46 2 20 18 28 29 18 32 147
Malaysia 22 562 1106 1182 997 758 844 5471 30 421 524 415 485 319 293 2487 52 983 1630 1597 1482 1077 1137 7958
Northern Mariana Islands 1 2 3 7 10 5 2 30 0 9 10 3 1 0 0 23 1 11 13 10 11 5 2 53
Marshall Islands 0 1 2 1 3 2 2 11 0 2 0 0 3 1 1 7 0 3 2 1 6 3 3 18
Micronesia 2 0 1 1 1 1 0 6 3 5 1 1 2 0 2 14 5 5 2 2 3 1 2 20
Mongolia 9 242 272 184 94 57 47 905 16 263 253 133 55 22 23 765 25 505 525 317 149 79 70 1670
Nauru 0 0 1 0 0 0 0 1 0 0 0 1 0 0 0 1 0 0 1 1 0 0 0 2
New Caledonia 0 2 2 1 1 1 3 10 0 4 2 2 3 0 0 11 0 6 4 3 4 1 3 21
New Zealand 0 10 14 5 6 4 10 49 1 15 8 4 3 5 3 39 1 25 22 9 9 9 13 88
Niue 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 1 1 1 0 0 0 0 0 2
Palau 1 0 1 1 2 2 1 8 0 0 3 0 0 0 0 3 1 0 4 1 2 2 1 11
Papua New Guinea 18 139 133 74 62 37 6 469 22 160 149 60 47 18 1 457 40 299 282 134 109 55 7 926
Philippines 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Pitcairn
Samoa 0 1 2 0 1 1 1 6 1 4 5 0 2 0 0 12 1 5 7 0 3 1 1 18
Singapore 0 14 28 73 88 65 130 398 2 10 15 30 32 24 38 151 2 24 43 103 120 89 168 549
Solomon Islands 3 16 12 9 9 7 4 60 0 16 15 4 2 7 4 48 3 32 27 13 11 14 8 108
Tokelau 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Tonga 0 1 0 0 4 0 10 15 0 1 1 1 0 1 4 8 0 2 1 1 4 1 14 23
Tuvalu 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Vanuatu 0 7 2 3 10 2 1 25 0 3 1 5 0 3 1 13 0 10 3 8 10 5 2 38
Vietnam 57 3250 6762 8855 8040 5162 8184 40 310 68 1571 2357 2508 2619 2409 4969 16 501 125 4821 9119 11 363 10659 7571 13 153 56 811
Wallis Futuna 0 1 0 1 1 0 1 4 0 0 0 0 3 2 0 5 0 1 0 1 4 2 1 9
WPR 1133 24 228 37 237 37 408 37 964 30 169 39 183 207 322 1392 17 516 21 213 16 414 14 771 11 907 16 613 99 826 2525 41 744 58 450 53 822 52 735 42 076 55 796 307 148
% 1 12 18 18 18 15 19 100 1 18 21 16 15 12 17 100 1 14 19 18 17 14 18 100
New SS+ males New SS+ females New SS+ males and females
*Breakdown of cases by age and sex was not available for the Philippines.
Sex ratio
(M/F)
1.5
1.5
1.1
2.1
1.4
1.1
1.4
2.4
2.4
0.9
1.7
1.5
2.2
2.2
1.3
1.6
0.4
1.2
1.0
0.9
1.3
1.0
2.7
1.0
0.5
2.6
1.3
1.9
1.9
2.4
0.8
2.1
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TABLE 8
Trend of notified tuberculosis cases (all types) in DOTS and non-DOTS areas
Year
1977 7 1251 257 95 67 7191 89 245 97 10 264 8 1075 608 7 2212 107 108 36 2760 355 62 150 222 855
1978 8 1292 230 183 78 64 6623 80 629 40 10 441 6 1107 595 14 2446 118 587 59 2964 411 89 131 68 650 294 647
1979 2 1542 216 30 205 81 71 7903 76 455 94 81 910 442 11 094 4 1123 542 9 2232 108 813 58 2800 452 71 7 184 11 821 308 161
1980 2 1457 196 37 210 73 55 8065 70 916 146 89 803 1101 11 168 6 1160 108 474 17 2525 112 307 59 2710 266 64 33 178 43 062 346 198
1981 6 1386 285 10 180 58 41 7729 65 867 187 98 532 585 10 970 26 7 1094 128 448 10 2418 116 821 49 2425 313 49 18 92 43 506 353 240
1982 6 1270 245 8158 98 654 19 163 48 49 7527 63 940 193 11 894 75 12 67 1325 107 437 17 2742 104 715 43 2179 324 0 45 12 173 51 206 355 645
1983 8 1219 276 7572 117 557 29 185 66 48 7301 62 021 127 91 572 455 11 634 74 15 73 1514 161 415 14 2954 106 300 41 2065 302 50 23 171 43 185 457 427
1984 12 1299 256 10 241 151 564 20 165 73 54 7843 61 521 111 85 669 671 10 577 58 12 75 1652 144 402 20 3505 151 863 37 2143 337 0 54 9 188 43 875 534 450
1985 5 1088 238 10 145 226 899 36 230 75 37 7545 58 567 103 87 169 571 10 569 64 15 66 2994 104 359 26 3678 151 028 1952 377 2 49 32 124 46 941 611 088
1986 8 906 212 10 325 265 095 17 199 79 49 7432 56 690 129 88 789 420 10 735 16 37 60 2819 98 320 13 2877 153 129 1760 292 35 27 131 47 557 650 256
1987 9 907 189 9106 313 604 16 173 63 34 7269 56 496 110 87 419 389 11 068 49 32 97 2433 74 296 38 3235 163 740 29 1616 334 9 24 22 90 55 505 714 475
1988 13 954 126 10 691 362 114 15 162 64 41 7021 54 357 208 74 460 320 10 944 27 11 77 2538 111 295 17 4261 183 113 29 1666 372 1 14 24 118 52 463 766 627
1989 5 952 128 7906 367 799 1 218 58 75 6704 53 112 121 70 012 274 10 686 28 7 68 2233 110 303 3 3396 217 272 37 1617 488 35 25 144 52 270 796 087
1990 15 1016 143 6501 375 481 1 252 59 40 6510 51 821 68 63 904 343 10 873 1659 130 348 2497 317 008 44 1591 382 1 23 23 140 47 536 888 409
1991 2 950 10 903 376 246 210 49 6283 50 612 57 864 1 951 329 11 059 1611 140 335 6 3401 207 371 309 19 16 234 54 509 784 409
1992 1011 16 148 12 240 83 6534 48 956 100 48 070 994 294 11 420 67 52 111 1516 140 317 2 2540 236 172 26 1512 364 1 23 30 147 56 594 4 433 480
1993 4 991 160 13 270 344 218 6 82 70 6537 47 437 46 999 1 905 318 12 075 61 151 1418 149 274 1 25 5516 174 189 49 1722 367 32 28 114 52 994 711 162
1994 15 112 363 804 4 225 89 94 6319 44 590 253 38 155 1 135 349 11 708 46 171 1730 4 132 352 2 41 5335 180 044 45 1677 332 0 23 19 152 51 763 11 723 716
1995 6 1073 0 14 599 357 829 1 203 0 0 6212 43 078 0 33 196 1 307 354 11 778 40 0 0 3010 0 0 307 1 19 8041 235 496 0 51 1889 352 1 20 36 79 55 739 4 774 721
1996 0 1073 0 14 857 469 358 0 200 86 0 6501 42 122 327 31 134 1 440 455 12 902 0 56 94 3010 0 205 323 2 5 5087 276 295 0 37 1889 289 1 22 0 0 74 711 0 942 481
1997 6 1145 0 15 629 418 903 0 171 91 0 6983 42 190 32 26 202 1 923 589 13 539 93 0 108 2987 0 0 328 0 15 7977 208 301 0 32 1977 318 0 21 0 184 84 964 14 834 722
1998 0 899 0 16 946 457 349 2 166 105 0 7673 44 016 276 30 008 2 165 463 14 115 97 49 138 2915 0 102 367 1 0 11 291 159 866 0 22 2120 295 0 30 18 178 87 449 0 839 121
1999 4 1073 272 19 266 460 169 3 192 93 0 7087 40 800 253 23 936 2 437 0 14 908 66 42 102 3348 0 0 348 2 32 12 189 145 807 0 31 1654 289 0 22 0 117 88 879 0 823 421
2000 3 1043 307 18 891 463 373 1 144 59 54 7578 39 384 210 21 782 2 234 449 15 057 75 34 91 3109 4 86 344 0 0 12 121 128 495 0 43 1728 303 0 24 0 152 89 792 0 806 970
2001 3 980 216 19 170 485 221 2 183 45 63 7262 35 489 189 37 268 2 382 465 14 830 58 56 95 3526 3 64 377 0 0 3470 107 133 0 22 1536 292 0 11 0 173 90 679 0 811 263
2002 2 1013 221 24 610 462 609 1 150 66 51 6608 32 828 189 34 967 2 621 388 14 389 53 51 127 3829 5 65 329 2 11 5324 118 408 0 30 1516 256 0 29 13 101 95 577 19 806 458
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TABLE 9
Trend of notified tuberculosis cases (new smear-positives) in DOTS and non-DOTS areas
Year
1977 881 145 41 13 373 22 6050 852 1285 182 29 57 22 917
1978 741 101 32 13 198 4 6313 903 1375 174 41 52 22 934
1979 807 114 41 12 806 21 34 633 6622 883 1197 184 28 52 57 388
1980 0 765 111 52 12 291 10 38 211 6819 5 10 967 17 275 1266 153 32 23 59 78 049
1981 6 723 97 39 12 214 34 43 868 6766 0 4 5 867 19 006 32 1062 174 18 10 34 33 243 118 202
1982 3 690 5801 19 236 98 32 12 649 17 46 735 7320 11 6 11 34 2 942 20 676 30 998 176 25 3 49 33 014 148 558
1983 6 596 5316 25 628 79 48 13 010 14 45 688 7251 3 6 32 60 6 870 18 657 25 860 130 23 7 55 32 612 150 982
1984 9 634 5507 38 367 82 52 13 277 42 561 6660 28 7 18 1061 21 291 20 992 155 25 3 55 30 426 161 230
1985 2 583 5235 53 078 99 48 4142 13 808 48 515 6682 4 8 14 363 69 4 870 39 571 949 155 23 3 51 34 217 208 493
1986 5 8715 60 949 86 49 4110 13 745 49 083 6653 5 4 10 320 66 0 606 50 624 839 101 18 5 36 30 381 226 410
1987 3 7173 75 45 4042 14 405 45 066 6924 22 18 271 55 4 839 72 150 740 115 12 7 26 34 530 186 522
1988 8246 65 44 3918 14 592 39 040 6718 276 62 1273 63 655 794 137 7 7 46 39 486 178 366
1989 5842 76 43 3768 14 710 33 968 133 6711 234 40 951 97 070 823 149 2 39 35 095 199 654
1990 5132 83 3670 15 498 30 700 124 6774 185 37 611 840 117 16 7 30 728 94 522
1991 8507 63 34 3564 15 285 28 790 526 140 6752 128 33 489 88 17 5 35 865 100 286
1992 536 12 910 90 184 4 75 40 15 540 17 736 459 158 6754 21 14 19 92 32 2 841 130 0 17 5 84 38 659 184 312
1993 1 557 68 9560 84 898 4 39 53 2429 15 210 99 16 630 765 108 6954 12 8 87 35 91 0 8 812 92 279 21 155 16 2 41 36 534 267 476
1994 11 058 104 729 1 60 38 40 14 777 184 18 375 752 171 6861 22 15 200 2 42 61 0 11 573 87 401 18 861 114 0 17 1 62 35 613 2 282 061
1995 3 0 0 11 101 134 488 0 68 0 0 0 14 367 0 11 754 726 141 6688 14 0 0 622 0 0 47 1 9 1652 94 768 0 15 455 109 1 9 6 30 37 550 0 314 624
1996 0 0 0 12 065 173 034 0 69 37 0 2116 12 867 144 11 420 886 204 7271 0 17 10 622 0 26 76 1 4 652 86 695 0 10 455 90 1 16 0 0 48 911 0 352 935
1997 6 171 0 12 686 195 396 0 66 41 0 1536 13 571 11 9957 1234 304 7596 14 0 11 1171 0 0 57 0 7 1195 83 353 0 14 432 113 0 12 0 66 53 647 1 375 801
1998 0 203 0 13 865 202 817 1 74 34 0 1869 11 935 50 10 359 1508 226 7802 26 11 28 1356 0 30 81 0 0 2107 71 663 0 7 480 140 0 16 0 38 54 873 0 393 244
1999 3 285 102 15 744 201 775 0 65 33 0 1566 12 909 59 9 559 1719 0 7960 15 17 16 1513 0 0 69 1 20 1914 73 373 0 17 465 93 0 10 0 43 53 805 0 393 801
2000 2 251 84 14 822 204 765 0 62 29 42 1940 11 853 54 8 216 1526 133 8156 27 11 15 1389 4 38 74 0 0 2267 67 056 0 13 248 109 0 15 0 63 53 169 0 385 434
2001 2 228 95 14 361 204 591 2 73 24 47 1853 11 408 64 11 805 1533 157 8309 19 15 8 1631 2 34 68 0 0 462 59 341 0 12 357 118 0 8 0 56 54 202 0 379 060
2002 1 210 112 17 258 194 972 1 75 27 31 1890 10 807 82 11 345 1829 147 7958 21 18 22 1670 2 21 88 1 9 926 65 148 0 18 549 108 0 23 0 38 56 811 1 372 219
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TABLE 10
Trend of tuberculosis notification rates per 100 000 (all types)
1976 40 10 207 44 81 58 176 87 505 89 65 76 20 38 65 338 52 123 154 74 221 115
1977 23 9 43 68 82 156 78 173 80 30 71 20 50 79 238 23 119 172 68 152
1978 26 9 133 30 55 76 141 70 71 80 21 71 19 100 84 260 38 126 192 95 128 134
1979 6 11 121 167 33 55 68 161 66 162 218 83 14 70 17 64 77 234 37 117 205 75 100 163 23
1980 6 10 106 206 33 49 51 158 61 243 236 411 81 19 71 78 15 113 84 233 37 112 118 69 471 155 80
1981 18 9 148 59 28 39 37 149 56 307 254 196 78 153 22 65 90 14 67 78 236 31 99 134 52 225 77 79
1982 17 8 123 118 10 106 25 31 49 145 54 322 82 441 38 93 77 72 14 142 83 204 27 88 130 0 45 150 140 91
1983 24 8 110 107 11 161 28 40 42 138 52 208 229 150 78 435 45 100 86 111 13 100 84 204 25 83 117 48 288 134 76
1984 34 8 95 142 14 105 24 46 45 145 51 179 211 217 70 305 34 85 91 95 12 154 106 284 23 84 125 0 56 113 145 75
1985 14 7 106 137 21 180 32 47 31 137 49 163 212 146 67 320 54 73 162 69 11 217 108 276 76 140 100 49 400 95 78
1986 22 6 94 136 25 85 28 44 40 135 47 202 212 101 67 80 128 64 148 66 10 93 85 274 68 102 36 338 97 77
1987 24 6 80 117 30 94 23 37 27 130 46 169 208 94 66 136 107 103 125 48 9 271 90 279 18 62 116 450 25 275 62 86
1988 35 6 52 135 33 88 22 34 33 123 45 315 177 72 65 71 26 79 127 69 9 121 118 308 18 63 122 50 15 300 79 82
1989 14 6 99 33 5 29 32 60 116 43 178 165 60 62 74 18 72 109 69 9 25 87 362 22 60 153 29 313 90 81
1990 32 6 56 79 33 6 34 33 32 112 42 100 149 76 61 79 79 10 67 516 27 59 120 50 23 288 96 72
1991 4 6 130 33 28 27 106 41 134 45 70 60 75 84 10 50 90 330 94 19 200 156 81
1992 6 188 71 32 45 111 39 141 110 23 77 61 146 106 103 69 82 9 67 65 377 16 54 109 50 23 375 96 82 29
1993 8 6 56 143 29 32 39 49 113 38 107 41 83 63 120 151 64 85 8 50 156 135 269 29 62 104 33 311 73 74 45.7
1994 152 30 21 29 41 64 109 36 329 105 24 88 59 98 171 77 36 74 10 100 256 130 272 27 59 91 0 23 211 92 71 79 45.5
1995 11 6 0 146 29 5 26 0 0 96 34 0 74 27 80 58 66 0 0 122 0 9 50 112 187 347 31 57 93 50 20 360 47 76 27 48.2
1996 0 6 0 145 38 0 25 39 0 99 34 409 69 29 103 63 0 98 75 120 111 5 100 29 116 399 22 56 74 50 22 0 0 99 0 57.9
1997 10 6 0 149 34 0 21 40 0 106 34 40 57 37 134 64 143 0 83 116 0 9 0 88 177 295 19 57 79 21 0 103 111 100 50.8
1998 0 5 0 158 36 10 20 46 0 115 35 333 65 40 105 66 139 80 103 111 50 10 50 0 245 222 13 61 71 30 180 98 112 50.6
1999 6 6 85 175 36 15 23 40 0 105 32 298 51 44 0 68 89 67 74 125 0 9 100 178 259 198 18 47 63 22 0 63 112 49.2
2000 5 5 91 157 37 6 17 26 35 112 31 250 46 42 103 68 109 56 79 131 33 41 9 0 0 236 168 25 53 74 24 0 76 117 49.0
2001 4 5 65 143 38 10 22 19 40 104 28 225 79 44 104 66 76 108 75 138 24 29 10 0 0 71 139 14 37 63 11 0 86 115 47.7
2002 3 5 63 178 36 6 18 27 32 95 26 217 74 47 84 60 70 98 118 150 38 29 9 100 55 95 151 0 17 36 55 28 130 49 119 127 46.9
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TABLE 11
Trend of tuberculosis notification rates per 100 000 (smear-positive cases)
1976 7 21 31 12 42 53 59 94 24 69
1977 6 24 30 12 39 47 30 55 88 32 58
1978 5 17 23 11 7 48 31 58 81 44 51
1979 6 18 28 11 36 92 49 30 50 83 29 46
1980 0 5 18 35 11 17 100 50 16 67 32 36 52 68 34 329 51
1981 18 5 15 26 10 56 113 48 0 13 33 28 38 21 43 75 19 125 28 61
1982 9 5 84 2 15 21 11 28 119 50 65 19 15 23 17 29 40 19 40 70 25 38 40 59
1983 18 4 75 3 12 29 11 23 114 49 18 18 44 41 43 25 36 16 34 50 22 88 43 57
1984 26 4 76 4 12 33 11 105 44 147 20 20 32 40 12 39 58 26 38 42 52
1985 6 4 71 5 14 30 75 11 118 42 20 29 15 20 2 33 26 72 37 57 23 38 39 57
1986 14 115 6 12 27 75 11 117 41 25 14 11 17 2 0 18 90 32 35 19 63 27 49
1987 8 92 10 26 72 12 107 41 61 19 14 2 29 23 123 28 40 13 88 18 53
1988 104 9 23 69 12 93 40 14 2 35 107 30 45 7 88 31 62
1989 73 10 24 65 12 80 29 39 11 25 24 162 31 47 25 24 54
1990 63 11 63 13 72 27 38 9 23 17 31 37 16 88 47
1991 101 8 19 60 12 67 12 30 37 6 20 13 27 17 63 53
1992 3 150 8 24 10 22 12 41 10 41 36 46 29 18 4 19 1 30 39 0 17 63 55 56
1993 2 3 24 103 7 21 19 37 42 12 129 38 17 28 37 24 8 4 20 3 0 50 20 142 13 44 16 22 26 51 16.6
1994 111 9 5 8 18 27 12 239 41 16 43 35 47 15 9 18 24 2 0 69 14 132 11 31 31 0 17 11 38 49 14 17.5
1995 6 0 0 111 11 0 9 0 0 0 11 0 26 15 32 33 23 0 0 25 0 1 50 53 38 140 9 14 29 50 9 60 18 51 0 19.6
1996 0 0 0 117 14 0 9 17 0 32 10 180 25 18 46 35 0 30 8 25 14 1 50 24 15 125 6 13 23 50 16 0 0 65 0 21.7
1997 10 1 0 121 15 0 8 18 0 23 11 14 22 24 69 36 22 0 8 46 0 2 0 41 27 118 8 13 28 12 0 37 70 7 22.9
1998 0 1 0 129 17 5 9 15 0 28 9 60 22 28 51 36 37 18 21 52 15 2 0 0 46 99 4 14 34 16 0 21 70 23.7
1999 5 2 32 143 17 0 8 14 0 23 10 69 21 31 0 36 20 27 12 56 0 2 50 111 41 100 10 13 20 10 0 23 68 23.5
2000 4 1 25 123 17 0 7 13 27 29 9 64 17 29 30 37 39 18 13 58 33 18 2 0 0 44 88 8 8 27 15 0 32 69 23.4
2001 3 1 28 107 17 10 9 10 30 27 9 76 25 28 35 37 25 29 6 64 16 15 2 0 0 9 77 8 9 25 8 0 28 68 22.3
2002 2 1 32 125 15 6 9 11 19 27 8 94 24 33 32 33 28 35 20 65 15 9 2 50 45 17 83 0 10 13 23 22 0 18 71 7 21.7
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TABLE 12
Input data used for estimation in the WHO Western Pacific Region
To be published in Global TB Control 2004. Visit www.who.int/gtb/tbestimates for 2001 estimates published in 2003 report, and for
2000 estimates published in Corbett et al. 2003. Arch Intern Med 163:1009-1021.
cfr = case fatality rate
Country DOTS non-DOTS DOTS non-DOTS DOTS non-DOTS DOTS non-DOTS
American Samoa 0.1 0.7 0.1 0.6 0.10 0.20 1.0 2.0
Australia 0.3 0.7 0.8 0.2 0.12 0.12 1.0 1.0
Brunei Darussalam 1.0 0.0 1.0 0.0 0.10 0.20 1.0 1.5
Cambodia 0.5 0.3 0.2 0.5 0.10 0.20 1.0 1.5
China 0.3 0.5 0.2 0.5 0.10 0.20 1.0 2.5
Cook Islands 0.4 0.4 0.0 0.7 0.10 0.20 1.0 2.0
Fiji 0.7 0.1 0.5 0.2 0.10 0.20 1.0 2.0
French Polynesia 0.8 0.0 1.0 0.0 0.10 0.20 1.0 2.0
Guam 0.5 0.3 0.2 0.5 0.10 0.20 1.0 2.0
Hong Kong (China) 0.5 0.4 1.0 0.0 0.10 0.10 1.0 1.0
Japan 0.3 0.6 0.6 0.4 0.15 0.15 1.3 1.3
Kiribati 1.0 0.0 1.0 0.0 0.10 0.20 1.0 2.0
Republic of Korea 0.0 0.9 0.0 1.0 0.12 0.12 1.0 1.5
Leo People’s Democratic Republic 0.4 0.4 0.2 0.6 0.10 0.20 1.5 2.5
Macao (China) 0.8 0.1 1.0 0.0 0.10 0.20 1.0 1.5
Malaysia 0.8 0.0 0.5 0.3 0.10 0.20 1.0 1.5
Northern Mariana Islands 0.7 0.1 0.8 0.0 0.10 0.20 1.0 2.0
Marshall Islands 0.8 0.0 1.0 0.0 0.10 0.20 1.0 2.0
Micronesia 0.5 0.3 1.0 0.0 0.10 0.20 1.0 2.0
Mongolia 0.7 0.0 0.7 0.0 0.10 0.20 1.0 2.5
Nauru 1.0 0.0 1.0 0.0 0.10 0.20 1.0 2.0
New Caledonia 0.2 0.6 0.4 0.3 0.10 0.20 1.0 2.0
New Zealand 0.5 0.5 1.0 0.0 0.12 0.12 1.0 1.0
Niue 1.0 0.0 1.0 0.0 0.10 0.20 1.0 2.0
Palau 1.0 0.0 0.2 0.5 0.10 0.20 1.0 2.0
Papua New Guinea 0.1 0.7 0.6 0.1 0.10 0.30 1.5 3.0
Philippines 0.6 0.3 0.4 0.4 0.10 0.30 1.0 2.5
Pitcairn
Samoa 0.7 0.1 0.4 0.3 0.10 0.20 1.0 2.0
Singapore 0.4 0.5 0.5 0.5 0.12 0.12 1.0 1.0
Solomon Islands 0.6 0.2 0.6 0.1 0.10 0.20 1.0 2.0
Tokelau 0.0 0.8 0.0 0.7 0.10 0.20 1.0 2.0
Tonga 1.0 0.0 0.3 0.4 0.10 0.20 1.0 2.0
Tuvalu 0.0 0.8 0.0 1.0 0.10 0.20 1.0 2.0
Vanuatu 0.4 0.4 0.4 0.3 0.10 0.20 1.0 2.0
Viet Nam 0.8 0.1 0.5 0.3 0.1 0.20 1.0 2.0
Wallis & Futuna 0.5 0.3 1.0 0.0 0.1 0.20 1.0 2.0
Proportion of TB cases treated
SS+ cfr SS+ HIV-ve TB (%)SS- Duration of HIV-ve TB (yr)
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TABLE 13
Summary of TB-HIV estimates for WHO Western Pacific Region, year 2001 (numbers in thousands)
All forms
Incident cases of TB
Country Population millions All cases % incr In adults In HIV+ve adults Attr to HIV SS+ All forms SS+ All cases in HIV+ve adults Attr to HIV
American Samoa 0.1 0.0 -0.03 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Australia 20.0 1.0 0.00 1.0 0.0 0.0 1.0 1.0 1.0 0.0 0.0 0.0
Brunei Darussalam 0.0 0.0 0.03 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cambodia 13.8 75.8 0.03 45.9 6.5 5.5 33.4 104.6 43.0 14.8 2.4 2.2
China 1294.9 1459.1 0.01 882.9 5.8 4.8 656.0 3240.9 1384.6 272.4 2.2 2.0
Cook Islands 0.0 0.0 -0.05 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Fiji 0.8 0.3 -0.04 0.2 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0
French Polynesia 0.0 0.0 -0.03 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Guam 0.2 0.1 0.02 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0
Hong Kong (China) 7.0 6.5 0.02 3.9 0.0 0.0 2.9 6.6 3.1 0.6 0.0 0.0
Japan 127.5 42.0 -0.03 19.5 0.1 0.1 18.9 56.0 25.0 5.2 0.0 0.0
Kiribati 0.0 0.0 0.02 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Republic of Korea 47.4 42.9 0.02 26.0 0.0 0.0 19.3 65.4 29.9 4.9 0.0 0.0
Lao People’s Democratic Republic 5.5 9.4 0.03 5.7 0.0 0.0 4.2 19.8 8.4 1.6 0.0 0.0
Macao (China) 0.5 0.4 0.01 0.2 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.0
Malaysia 24.0 22.7 -0.01 13.7 0.3 0.2 10.2 28.9 12.3 3.5 0.1 0.1
Northern Mariana Islands 0.1 0.0 0.05 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Marshall Islands 0.1 0.0 0.02 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0
Micronesia 0.1 0.1 0.01 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0
Mongolia 2.6 5.4 0.02 3.2 0.0 0.0 2.4 6.9 3.2 0.9 0.0 0.0
Nauru 0.0 0.0 -0.03 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
New Caledonia 0.2 0.2 0.02 0.1 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0
New Zealand 3.8 0.4 0.01 0.2 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.0
Niue 0.0 0.0 -0.06 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Palau 0.0 0.0 0.03 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Papua New Guinea 6.0 14.0 0.03 9.0 0.3 0.3 6.0 30.0 16.0 3.1 0.1 0.1
Philippines 78.6 251.4 0.02 152.1 0.6 0.5 113.1 424.4 176.3 45.0 0.2 0.2
Pitcairn 0.0
Samoa 0.2 0.1 -0.04 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0
Singapore 4.2 1.8 -0.01 0.8 0.0 0.0 0.8 1.9 0.9 0.2 0.0 0.0
Solomon Islands 0.5 0.4 0.03 0.3 0.0 0.0 0.2 0.6 0.3 0.1 0.0 0.0
Tokelau 0.0 0.0 -0.05 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Tonga 0.1 0.0 -0.04 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Tuvalu 0.0 0.0 -0.04 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Vanuatu 0.2 0.2 0.03 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0
Viet Nam 80.3 154.5 0.02 93.5 1.7 1.4 69.4 211.9 81.5 20.2 0.4 0.4
Wallis & Futuna 0.0 0.0 -0.04 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
TB prevalence TB deaths
To be published in Global TB Control 2004. Visit www.who.int/gtb/tbestimates for 2001 estimates published in 2003 report, and for 2000 estimates published in Corbett et al. 2003. Arch Intern Med 163:1009-1021.
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TABLE 14
Summary of TB-HIV estimates for the WHO Western Pacific Region, 2001 (rates per 100 000 population)
All forms
Incident cases of TB
TB prevalence
To be published in Global TB Control 2004. Visit www.who.int/gtb/tbestimates for 2001 estimates published in 2003 report, and for 2000 estimates published in Corbett et al. 2003. Arch Intern Med 163:1009-1021.
TB deaths TB cfr (%)
In HIV+ve % attr In HIV+ve % attr % AIDS deaths % TB deaths HIV int prev in new
Country All cases % incr In adults adults  to HIV SS+ All forms SS+ All cases adults to HIV from TB in HIV+ves HIV-ve HIV+ve adult TB cases (%)
American Samoa 30 -0.05 18 0.0 0.0 14 58 26 6.0 0.0 0.1 0.0 0.0 19.8 40.0 0.1
Australia 6 -0.01 3 0.0 2.0 3 6 3 1.0 0.0 1.0 0.0 0.0 10.0 10.0 2.0
Brunei Darussalam 59 0.00 36 0.4 1.0 26 59 26 4.0 0.0 0.9 0.0 0.0 7.0 10.0 1.2
Cambodia 549 0.00 332 47.4 11.9 242 758 311 107.1 17.6 15.1 0.0 0.0 17.9 37.0 14.3
China 113 0.00 68 0.4 0.5 51 250 107 21.0 0.2 0.7 0.0 0.0 19.0 37.0 0.7
Cook Islands 30 -0.05 18 0.0 0.0 14 56 22 5.7 0.0 0.1 0.0 0.0 19.0 40.0 0.1
Fiji 30 -0.05 18 0.1 0.3 14 43 18 5.0 0.0 0.4 0.0 0.0 16.0 31.0 0.4
French Polynesia 30 -0.05 18 0.4 2.0 14 33 16 3.8 0.1 1.6 0.0 0.0 12.0 16.0 2.4
Guam 91 0.00 55 1.5 2.3 41 148 61 16.4 0.5 3.1 0.0 0.0 17.8 36.0 2.8
Hong Kong (China) 93 0.00 56 0.3 0.4 42 95 44 8.0 0.0 0.3 0.0 0.0 9.0 12.0 0.5
Japan 33 -0.04 15 0.1 0.5 15 44 20 4.0 0.0 0.2 0.0 0.0 12.0 12.0 0.5
Kiribati 91 0.00 55 0.0 0.0 41 91 41 7.0 0.0 0.0 0.0 0.0 7.0 10.0 0.0
Republlic of Korea 91 0.01 55 0.0 0.0 41 138 63 10.2 0.0 0.1 0.0 0.0 11.0 11.0 0.1
Lao People’s Democratic Republic 170 0.00 103 0.3 0.3 76 359 152 29.0 0.1 0.4 0.0 0.0 17.0 36.0 0.3
Macao (China) 85 0.00 52 0.6 0.9 38 92 46 10.0 0.1 0.7 0.0 0.0 12.0 14.0 1.1
Malaysia 95 -0.03 57 1.2 1.7 43 121 51 15.0 0.3 2.1 0.0 0.0 15.0 28.0 2.1
Northern Mariana Islands 91 0.00 55 0.0 0.0 41 112 54 13.0 0.0 0.0 0.0 0.0 15.0 22.0 0.1
Marshall Islands 91 0.00 55 0.0 0.0 41 97 47 10.0 0.0 0.0 0.0 0.0 11.0 14.0 0.0
Micronesia 91 0.00 55 0.0 0.0 41 111 61 12.7 0.0 0.0 0.0 0.0 14.0 17.0 0.0
Mongolia 209 0.00 127 0.0 0.0 94 270 123 37.0 0.0 0.0 0.0 0.0 17.0 28.0 0.0
Nauru 31 -0.05 18 0.0 0.0 14 30 13.7 2.2 0.0 0.0 0.0 0.0 7.0 10.0 0.1
New Caledonia 91 0.00 55 0.8 1.3 41 151 72 16.9 0.3 1.6 0.0 0.0 19.0 35.0 1.5
New Zealand 11 0.00 5 0.1 1.7 5 11 5 1.1 0.0 0.8 0.0 0.0 10.0 10.0 1.8
Niue 30 -0.05 18 0.0 0.0 14 30 14 2.0 0.0 0.0 0.0 0.0 7.0 10.0 0.1
Palau 91 0.00 55 0.0 0.0 41 130 41 10.0 0.0 0.1 0.0 0.0 11.0 30.0 0.1
Papua New Guinea 254 0.00 154 5.8 3.1 114 545 290 56.0 2.2 3.5 0.0 0.0 22.0 38.0 3.8
Philippines 320 0.00 194 0.8 0.3 144 540 224 57.2 0.3 0.5 0.0 0.0 18.0 36.0 0.4
Pitcairn
Samoa 30 -0.05 18 0.1 0.3 14 44 17 5.0 0.0 0.4 0.0 0.0 16.0 32.0 0.4
Singapore 43 -0.03 20 1.1 5.5 19 44 21 4.9 0.1 2.6 0.0 0.0 11.0 12.0 5.7
Solomon Islands 91 0.00 55 0.0 0.0 41 125 58 14.8 0.0 0.1 0.0 0.0 16.0 30.0 0.1
Tokelau 30 -0.05 18 0.0 0.0 14 61 27 6.3 0.0 0.1 0.0 0.0 21.0 43.0 0.1
Tonga 30 -0.05 18 0.0 0.0 14 41 14 3.0 0.0 0.1 0.0 0.0 11.0 28.0 0.1
Tuvalu 30 -0.05 18 0.0 0.0 14 61 27 6.0 0.0 0.1 0.0 0.0 19.0 35.0 0.1
Vanuatu 91 0.00 55 0.0 0.0 41 147 67 16.3 0.0 0.1 0.0 0.0 18.0 35.0 0.1
Viet Nam 192 0.00 116 2.1 1.5 86 264 102 25.1 0.5 2.0 0.0 0.0 13.0 27.0 1.8
Wallis & Futuna 30 -0.05 18 0.0 0.0 14 37 21 4.3 0.0 0.0 0.0 0.0 14.0 17.0 0.1
cfr = case fatality rate
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TABLE 15
Treatment outcome of new smear-positive cases registered in 2002 in DOTS areas
Non evaluated Completed Transferred Treatment
Country Registered  (% ) Cured treatment Defaulted Failed Died out success
American Samoa 0
Australia 133 15.0 18.0 48.1 3.8 1.5 9.8 3.8 66.2
Brunei Darussalam 147 0.0 43.5 12.2 2.7 0.7 8.8 32.0 55.8
Cambodia 14 277 0.0 89.3 2.5 2.9 0.4 4.0 0.9 91.8
China 176 476 0.7 94.0 2.1 0.7 0.7 1.1 0.6 96.1
Cook Islands 1 0.0 100.0 0.0 0.0 0.0 0.0 0.0 100.0
Fiji 73 0.0 84.9 0.0 5.5 0.0 8.2 1.4 84.9
French Polynesia 45 0.0 80.0 0.0 8.9 4.4 6.7 0.0 80.0
Guam 62 0.0 53.2 17.7 0.0 0.0 11.3 17.7 71.0
Hong Kong (China) 1450 2.8 71.6 6.4 3.4 8.6 4.1 3.0 78.0
Japan 6026 6.8 51.4 23.5 2.1 4.8 11.4 0.0 74.9
Kiribati 71 8.5 78.9 7.0 1.4 1.4 2.8 0.0 85.9
Republic of Korea 0
Leo People’s Democratic Republic 1484 3.8 66.8 9.8 8.4 0.7 8.0 2.6 76.6
Macao (China) 147 2.0 85.7 3.4 3.4 0.0 3.4 2.0 89.1
Malaysia 8277 4.0 0.0 79.4 7.2 0.0 9.4 0.0 79.4
Northern Mariana Islands 19 0.0 0.0 73.7 0.0 0.0 0.0 26.3 73.7
Marshall Islands 22 0.0 36.4 50.0 4.5 0.0 4.5 4.5 86.4
Micronesia 8 0.0 100.0 0.0 0.0 0.0 0.0 0.0 100.0
Mongolia 1631 0.1 83.4 3.3 3.9 4.5 2.3 2.6 86.7
Nauru 2 0.0 100.0 0.0 0.0 0.0 0.0 0.0 100.0
New Caledonia 19 0.0 84.2 0.0 5.3 0.0 10.5 0.0 84.2
New Zealand 90 91.1 0.0 8.9 0.0 0.0 0.0 0.0 8.9
Niue 0
Palau 1 0.0 100.0 0.0 0.0 0.0 0.0 0.0 100.0
Papua New Guinea 469 3.8 45.4 21.5 22.8 0.4 3.4 2.6 67.0
Philippines 55 402 0.0 74.5 13.1 6.0 1.3 2.3 2.7 87.6
Pitcairn
Samoa 22 4.5 40.9 36.4 0.0 0.0 18.2 0.0 77.3
Singapore 451 0.7 0.0 87.8 4.7 0.4 5.8 0.7 87.8
Solomon Islands 118 3.4 66.1 22.9 6.8 0.0 0.8 0.0 89.0
Tokelau
Tonga 12 0.0 66.7 25.0 0.0 0.0 8.3 0.0 91.7
Tuvalu 0
Vanuatu 48 0.0 64.6 22.9 0.0 2.1 10.4 0.0 87.5
Viet Nam 55 236 1.9 89.2 1.6 1.5 0.9 3.0 1.9 90.8
Wallis & Futuna 1 0.0 100.0 0.0 0.0 0.0 0.0 0.0 100.0
Total 322 220 1.0 85.8 6.6 2.2 1.0 2.3 1.2 92.4
Outcomes of treatment (%)
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TABLE 16
Treatment outcome of new smear-positive cases registered in 2001 in non-DOTS areas
Non evaluated Completed Transferred Treatment
Country Registered  (% ) Cured treatment Defaulted Failed Died out success
American Samoa 2 0.0 0.0 100.0 0.0 0.0 0.0 0.0 100.0
Australia 70 15.7 20.0 58.6 1.4 0.0 0.0 4.3 78.6
Brunei Darussalam 0
Cambodia 0
China 14 024 2.4 77.1 8.6 1.3 3.0 5.4 2.2 85.8
Cook Islands 0
Fiji 0
French Polynesia 0
Guam 0
Hong Kong (China) 407 58.2 4.4 4.2 25.8 1.2 0.5 5.7 8.6
Japan 4108 60.5 18.4 15.6 1.2 3.8 0.4 0.0 34.0
Kiribati 0
Republic of Korea 5863 4.0 77.2 1.3 1.4 1.2 3.3 11.5 78.5
Lao People’s Democratic Republic 79 0.0 36.7 21.5 10.1 2.5 25.3 3.8 58.2
Macao (China) 0
Malaysia 0
Northern Mariana Islands 0
Marshall Islands 0
Micronesia 0
Mongolia 0
Nauru 0
New Caledonia 0
New Zealand 0
Niue 0
Palau 0
Papua New Guinea 0
Philippines 0
Pitcairn
Samoa 0
Singapore 400 0.8 0.0 65.5 21.0 0.5 11.0 1.3 65.5
Solomon Islands 0
Tokelau
Tonga 0
Tuvalu 0
Vanuatu 9 0.0 22.2 66.7 0.0 0.0 0.0 11.1 88.9
Viet Nam 0
Wallis & Futuna 0
Total 24 962 13.2 64.7 9.1 2.0 2.6 4.2 4.1 73.8
Outcomes of treatment (%)
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TABLE 17
Treatment outcome of re-treatment cases registered in 2001 in DOTS areas
Non evaluated Completed Transferred Treatment
Country Registered  (% ) Cured treatment Defaulted Failed Died out success
American Samoa 0
Australia 4
Brunei Darussalam 0
Cambodia 707 0.0 87.4 4.2 0.0 0.0 0.0 0.8 91.7
China 35 991 1.0 88.2 4.9 0.0 0.0 0.0 0.8 93.1
Cook Islands 0
Fiji 0
French Polynesia 0
Guam 0
Hong Kong (China) 209 5.3 56.9 7.7 0.0 0.0 0.0 3.3 64.6
Japan 711 11.0 49.6 18.3 0.0 0.0 0.0 0.0 67.9
Kiribati 0
Republic of Korea 0
Lao People’s Democratic Republic 99 18.2 41.4 10.1 0.0 0.0 0.0 3.0 51.5
Macao (China) 47 4.3 63.8 19.1 0.0 0.0 0.0 2.1 83.0
Malaysia 0
Northern Mariana Islands 0
Marshall Islands 0
Micronesia 20 0.0 40.0 35.0 0.0 0.0 0.0 0.0 75.0
Mongolia 113 0.0 54.0 17.7 0.0 0.0 0.0 5.3 71.7
Nauru 0
New Caledonia 0
New Zealand 28 100.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Niue 0
Palau 0
Papua New Guinea 826 0.7 23.4 36.3 0.0 0.0 0.0 2.1 59.7
Philippines 0
Pitcairn
Samoa 1 0.0
Singapore 0
Solomon Islands 0
Tokelau
Tonga 1 0.0 100.0 0.0 0.0 0.0 0.0 0.0 100.0
Tuvalu 0
Vanuatu 0
Viet Nam 5895 0.0 80.0 5.5 0.0 0.0 0.0 1.9 85.5
Wallis & Futuna 0
Total 44 652 1.1 84.9 5.8 1.8 2.8 2.6 1.0 90.7
Outcomes of treatment (%)
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CHART 1
Notification of all cases by country, Western Pacific Region, 2002
(rate per 100 000)
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CHART 2
Notification of new smear-positive cases by country,
Western Pacific Region, 2002 (rate per 100 000)
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CHART 4
DOTS case detection rate of new smear-positive cases,
countries with a high burden, Western Pacific Region, 2002 (%)
CHART 3
Notification rate of new smear-positive cases by age and sex*
in DOTS areas, Western Pacific Region, 2002
*Excluding the Philippines.
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CHART 5
Treatment success of new smear-positive cases under DOTS in
countries with a high burden, Western Pacific Region, 2002 (%)
CHART 6
DOTS progress in countries with a high burden in the Western
Pacific Region, 1998–2002
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Definitions of tuberculosis cases
A case of tuberculosis: A patient in whom tuberculosis has been bacteriologically confirmed, or
has been diagnosed by a clinician. Any person given treatment for tuberculosis should be
recorded.
All types: The sum of new smear-positive pulmonary, relapse, new smear-negative pulmonary
and extrapulmonary cases.
New smear-positive pulmonary: A patient who has never received treatment for tuberculosis or
has taken anti-tuberculosis drugs for less than four weeks and who has one of the following:
• two or more initial sputum smear examinations positive for acid fast bacilli (AFB),
• one sputum examination positive for AFB plus radiographic abnormalities consistent with
active pulmonary tuberculosis as determined by a treating medical officer; or
• one sputum specimen positive for AFB and at least one sputum that is culture positive for
AFB.
New smear-negative pulmonary: A case of pulmonary tuberculosis that does not meet the
above definition for smear-positive tuberculosis:
Extrapulmonary tuberculosis: Tuberculosis of organs other than the lungs,  e.g. pleura, lymph
nodes, abdomen, genito-urinary tract, skin, joints and bones, meninges. Diagnosis should
be based on one culture-positive specimen, or histological or strong clinical evidence
consistent with active extrapulmonary tuberculosis, followed by a decision by a clinician to
treat with a full course of anti-tuberculosis chemotherapy. (A patient diagnosed with both
pulmonary and extrapulmonary tuberculosis should be classified as a case of pulmonary
tuberculosis.)
Retreatment cases: Relapses, failures and defaulters.
Relapse: A patient previously treated for tuberculosis and declared cured or treatment completed,
who is later diagnosed with bacteriologically positive (culture smear) tuberculosis.
Definitions of treatment outcome
Cured: A patient who is sputum smear-negative in the last month of treatment and on at least one
previous occasion.
Completed treatment: A patient who has completed treatment but who does not meet the criteria
to be classified as a cure or a failure.
Treatment success: The sum of patients who are cured and those who have completed treatment.
Died: A patient who dies for any reason during the course of treatment.
Failure: A patient who, while undergoing treatment, is sputum smear-positive at five months or later
during the course of treatment.
ANNEX 1
Definitions7
7 WHO, IUATLD, KNCV. Revised international definitions in tuberculosis control. Int J Tuberc Lung Dis 2001;
5: 213-215.
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Defaulted: A patient who has interrupted treatment for two consecutive months or more.
Transferred out: A patient who has been transferred to another recording and reporting unit and
for whom the treatment outcome is not known.
Not evaluated: Patients who did not have the treatment outcome evaluated.
Note: In countries where culture is current practice, patients can be classified as cured or failure on the
basis of culture results.
Indicators to assess treatment outcome
Cure rate: Proportion of cured cases out of all cases registered in a certain period (in 2001 in this
report).
Treatment success rates: The sum of the proportion of patients who were cured and patients
who completed treatment out of all cases registered in a certain period. The global target is
a 85% cure rate and a greater treatment success rate.
The cure rate and treatment success rate are expressed as a percentage of registered
cases. The number of new cases registered for treatment in 2001 (reported in 2003) is
compared to the number of cases notified as smear-positive in 2001 (reported in 2002).
Differences may arise because NTPs do not compile data at the end of each calendar year,
diagnoses may be incorrect, patients are lost between diagnosis and the start of treatment,
or records are lost. Second, the fraction of registered cases was evaluated for outcome. All
registered cases should be evaluated. Third, data on the six standard, mutually exclusive
outcomes of treatment are compiled. These figures are reported as percentages of all
registered cases, so that the possible outcomes plus the fraction of cases not evaluated sum
to 100%. When a country states the number of patients registered for treatment, but gives no
outcomes, no result is reported rather than zero treatment success. Although treatment
outcomes are expressed as percentages, they are referred to as rates. The six possible
outcomes plus the fraction of cases not evaluated sum to 100%. If the number of registered
cases is lower than the sum of the six outcomes or is missing, the denominator for treatment
success will be the number evaluated or the number of smear-positive cases notified in the
previous year, whichever is greater.
Case detection rate and DOTS detection rate
DOTS: The recommended strategy for tuberculosis control. It comprises:
• government commitment to ensuring sustained, comprehensive tuberculosis control ac-
tivities;
• case detection by sputum smear microscopy among symptomatic patients self-reporting to
health services;
• standardized short-course chemotherapy using regimens of six to eight months, for at
least all confirmed smear-positive cases (Good case management includes DOT during
the intensive phase for all new sputum smear-positive cases, the continuation phase of
rifampicin-containing regimens and the whole re-treatment regimen);
• a regular, uninterrupted drug supply of all essential anti-tuberculosis drugs; and
• a standardized recording and reporting system that allows assessment of case-finding
and treatment results for each patient and of the tuberculosis control programme perfor-
mance overall.
Targets for tuberculosis control established by the World Health Assembly:
• to detect 70% of the estimated new sputum smear-positive tuberculosis cases; and
• to cure 85% of the sputum smear-positive tuberculosis cases detected.
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Case notifications represent only a fraction of the true number of cases in a country because the
coverage by effective NTPs will be incomplete.
The estimated case detection rate is defined as:
Case detection rate (%) =  
     Annual new smear-positive notifications (country)
                                          Estimated annual new smear-positive incidence (country)
DOTS detection rate refers to case detection under DOTS:
DOTS detection rate (%) =  Annual new smear-positive notifications under DOTS
                                           Estimated annual new smear-positive incidence (country)
The case detection rate and DOTS detection rate are identical when a country has a 100% DOTS
enrolment rate. Updated estimated incidence for 2002 in this report was provided by WHO,
Geneva.
Population with access to DOTS: The country’s population that has access to units implementing
DOTS.
DOTS enrolment rate (%): This indicates a proportion of cases enrolled in DOTS out of notified
cases.
DOTS enrolment rate (all types) (%) = Annual notifications of all types under DOTS                                                                 Total of annual notifications of all types
DOTS enrolment rate (New S+) (%) =   Annual notification of new S+ under DOTS                                                                    Total of annual notifications of new S+
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Formulas for estimating
tuberculosis incidence,
prevalence and deaths
ANNEX 2
Source: Corbett EL, Watt CJ, Walker N. et al. The Growing Burden of Tuberculosis. Global Trends and Interactions With the HIV Epidemic. Arch Int
Med 2003; 163(9): 1009-1021.
Formulas
1. I = T/d and I s= Ts/ds
2. P = tl and P s= tsls
3. Is/N = λk
4. D = fl and D s= fls
5. I = Ia*+Ia-+In
or
I = ma+ra+Na++ma-ra-Na-+maraNa
6. IRR = ma+ra+/ma-ra-=(Ia+/Na+)/(Ia-/Na-)
7. Ia+/Ia = IRR(Na+/Na)/[1+(Na-/Na)(IRR-1)]
8. Ia*  =  Ia+-Ia-Na+/Na-
9. Da* = Da+-f - (I+-Ia*)
Definitions
N = Population
I = Incidence of TB (No. of New Cases of TB per year)
P = Prevalence of TB
T = TB Case Notifications (per year)
D = Deaths from TB
IRR = TB Incidence Rate Ratio (TB Incidence Rate in Human Immunodeficiency Virus
[HIV]-Positive Persons/TB Incidence in HIV-Negative persons)
d = Proportion of Cases Notified (Case Detection Rate)
t = Average Duration of TB Disease (Years)
λ = Rate of Infection With Mycobacterium tuberculosis (MTB) (Annual Rate of Infection
per Person per year)
k = Ratio of Incidence of Smear-Positive TB to Rate of MTB Infection
f = Proportion of TB Patients Who Die From TB (Case Fatality Rate [CFR])
m = Prevalence of Infection with MTB
r = Rate of Progression to TB disease in MTB-Infected Individuals (per Person per year)
s = Sputum Smear-Positive TB (No Subscript Implies All Forms)
a = Adult (15-49 Years Old)
n = Other Age Groups (<15 or >49 Years Old), Assumed HIV-Uninfected
+ = HIV Positive
- = HIV Negative
* = Attributable to HIV Infection
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ANNEX 3
Statistical methods
Increasing or decreasing trends of times series were assessed using a non-parametric Spearman
test between the observations and time.8 The series were re-sampled 1000 times for a bootstrap
test.
Rates of change per year were assessed by estimating the slope of the log-transformed rates
against time.
All p values found smaller than 0.05 were considered statistically significant.
The statistical analysis was carried out using the R language,9 freely downloadable from the
Internet.10
8 Siegel, S. & N.J. Castellan, 1988. Non-parametric statistics. McGraw-Hill, New York. 399  pp.
9 Ross Ihaka and Robert Gentleman. R: A language for data analysis and graphics. Journal of
Computational and Graphical Statistics, 5(3):299-314, 1996.
10http://www.r-project.org
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